How to ensure effective filtration of critical media and avoid issues caused by non-optimal filter selection
If not removed, bacteria (including Mycoplasma) present in cell culture media can result in process contamination and cell culture loss. Media sterilization is often performed using filtration, however, due to the complex nature of today’s cell culture medias, as well as batch to batch variation, this can pose challenges for biopharmaceutical manufacturers and their choice of filter configuration is key to the success of the operation.
This webinar will look at why cell culture media can be so problematic to filter and introduce some case studies that examine bacterial retention properties of different filters in complex media.
It will then go on to discuss key considerations when selecting a filter for this application and how this can help a manufacturer process complex solutions consistently - even when batch to batch variation exists – maintaining bioreactor or culture vessel sterility during this critical upstream phase.
Register today to begin optimizing your cell culture media filtration system.
Presented by
David Heaney,
Market development manager
David has been at Parker for three and a half years working first as an applications scientist, supporting customers to develop their processes with Parker’s range of bioprocessing technology, before moving to the role of market development manager. David now leads the biopharmaceutical marketing team looking at ways to bring Parker’s expertise in automation and control to the industry.
Katy Angus,
Research project manager
Katy has been with Parker for seven years as a Research Project Manager. Prior to this Katy held research roles within the development of downstream processes. Katy currently manages the laboratory functions of research, technical support and quality control at Parker Bioscience Filtration.
Paul Hymus,
Product manager - filtration
Paul has been with Parker for over 25 years during which time he has held various technical and product development roles supporting the growth of the Parker filtration business. Before moving into his current role as product manager for the life sciences filtration product range, Paul was responsible for the development of Parker’s point of use infection control portfolio.